Fortelyzin® in the treatment of ischemic stroke. Case report
- Authors: Ubushieva S.T.1, Kazakov D.N.1, Lebedeva A.Y.1,2
-
Affiliations:
- Moscow Multidisciplinary Clinical Center “Kommunarka“
- Pirogov Russian National Research Medical University
- Issue: Vol 24, No 11 (2022)
- Pages: 777-782
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/144211
- DOI: https://doi.org/10.26442/20751753.2022.11.202025
- ID: 144211
Cite item
Full Text
Abstract
Given the current high incidence of cerebral circulatory disorders and the challenging treatment of such patients, developing therapies and medications for these conditions is urgent. The proportion of patients undergoing various reperfusion techniques is increasing, and so is the medical community's need for novel agents with high efficacy and low complication rate.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sarbinaz T. Ubushieva
Moscow Multidisciplinary Clinical Center “Kommunarka“
Email: alebedeva-md@yandex.ru
ORCID iD: 0000-0001-8529-3903
neurologist
Russian Federation, MoscowDmitry N. Kazakov
Moscow Multidisciplinary Clinical Center “Kommunarka“
Email: alebedeva-md@yandex.ru
ORCID iD: 0000-0003-0263-6670
Head of the Resuscitation and Intensive Care Unit
Russian Federation, MoscowAnastasiya Yu. Lebedeva
Moscow Multidisciplinary Clinical Center “Kommunarka“; Pirogov Russian National Research Medical University
Author for correspondence.
Email: alebedeva-md@yandex.ru
ORCID iD: 0000-0002-4060-0786
D. Sci. (Med.)
Russian Federation, Moscow; MoscowReferences
Supplementary files
